tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MNKD Stock Latest News

MannKind: Pediatric Expansion, Improved Dosing, and Pipeline Diversification Drive Buy Rating on Afrezza Growth Potential
RatingsMannKind: Pediatric Expansion, Improved Dosing, and Pipeline Diversification Drive Buy Rating on Afrezza Growth Potential
7d ago
MNKD
MannKind says first patient enrolled in INHALE-1ST study of Afrezza
PremiumThe Fly
MannKind says first patient enrolled in INHALE-1ST study of Afrezza
7d ago
MNKD
Morning Movers: USA Rare Earth surges after government funding pact
PremiumThe Fly
Morning Movers: USA Rare Earth surges after government funding pact
21d ago
AAUC
CRWV
MannKind receives FDA approval for Afrezza dosage label
PremiumThe Fly
MannKind receives FDA approval for Afrezza dosage label
21d ago
MNKD
MannKind Targets Newly Diagnosed Youth With Afrezza: What Investors Should Watch
PremiumCompany Announcements
MannKind Targets Newly Diagnosed Youth With Afrezza: What Investors Should Watch
1M ago
MNKD
Multiple 2026 Regulatory, Pipeline, and Partnership Catalysts Underscore MannKind’s Underappreciated Growth Potential and Support Reiterated Buy Rating
PremiumRatingsMultiple 2026 Regulatory, Pipeline, and Partnership Catalysts Underscore MannKind’s Underappreciated Growth Potential and Support Reiterated Buy Rating
1M ago
MNKD
MannKind shares not pricing in ‘multiple tailwinds,’ says H.C. Wainwright
Premium
The Fly
MannKind shares not pricing in ‘multiple tailwinds,’ says H.C. Wainwright
1M ago
MNKD
MannKind provides business updates, 2026 growth drivers
Premium
The Fly
MannKind provides business updates, 2026 growth drivers
1M ago
MNKD
3 ‘Strong Buy’ Stocks to Buy Today,12/24/2025, According to Top Analysts
PremiumMarket News
3 ‘Strong Buy’ Stocks to Buy Today,12/24/2025, According to Top Analysts
2M ago
NOW
ENGN
MannKind announes FDA approval of sNDA for FUROSCIX On-body Infusor
PremiumThe Fly
MannKind announes FDA approval of sNDA for FUROSCIX On-body Infusor
2M ago
MNKD
MannKind’s Clofazimine Inhalation Study Terminated: Implications for Investors
PremiumCompany Announcements
MannKind’s Clofazimine Inhalation Study Terminated: Implications for Investors
2M ago
MNKD
MannKind says FDA accepts for review its sNDA of of FUROSCIX ReadyFlow
PremiumThe Fly
MannKind says FDA accepts for review its sNDA of of FUROSCIX ReadyFlow
3M ago
MNKD
MannKind initiated with a Buy at Truist
PremiumThe FlyMannKind initiated with a Buy at Truist
3M ago
MNKD
MannKind price target lowered to $10 from $15 at Oppenheimer
Premium
The Fly
MannKind price target lowered to $10 from $15 at Oppenheimer
3M ago
MNKD
MannKind’s Strategic Advancements and Product Potential Justify Buy Rating Despite MNKD-101 Discontinuation
Premium
Ratings
MannKind’s Strategic Advancements and Product Potential Justify Buy Rating Despite MNKD-101 Discontinuation
3M ago
MNKD
Midday Fly By: Insurers slip as Senate spending bill lacks ACA extension
PremiumThe Fly
Midday Fly By: Insurers slip as Senate spending bill lacks ACA extension
3M ago
JD
CNC
H.C. Wainwright remains bullish on MannKind despite disappointing MNKD-101 news
PremiumThe Fly
H.C. Wainwright remains bullish on MannKind despite disappointing MNKD-101 news
3M ago
MNKD
MannKind’s Resilience and Growth Potential: A Buy Rating Amid Setbacks and Opportunities
PremiumRatings
MannKind’s Resilience and Growth Potential: A Buy Rating Amid Setbacks and Opportunities
3M ago
MNKD
MannKind Halts Phase 3 Trial for MNKD-101
PremiumCompany Announcements
MannKind Halts Phase 3 Trial for MNKD-101
3M ago
8K
MNKD
MannKind provides update on Phase 3 ICoN-1 trial of nebulized clofazimine
PremiumThe FlyMannKind provides update on Phase 3 ICoN-1 trial of nebulized clofazimine
3M ago
MNKD
MannKind Corporation Reports Strong Q3 2025 Growth
Premium
Company Announcements
MannKind Corporation Reports Strong Q3 2025 Growth
3M ago
MNKD
MannKind’s Record Q3 2025 Earnings and Strategic Moves
Premium
Company Announcements
MannKind’s Record Q3 2025 Earnings and Strategic Moves
3M ago
MNKD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >